Current and future prospective of pharmaceutical manufacturing in Saudi Arabia

This observational descriptive study that was carried out with the objective of exploring the contribution of the local pharmaceutical industry to the Saudi drug security. Using a drug formulary provided from the Saudi Food and Drug Authority, containing all registered pharmaceutical products available in Saudi Arabia, we extracted information about drug class, drug type, country and place of manufacturing, shelf-life and price. Results showed that the majority of drugs in the market are manufactured in Europe (43.86%), followed by Saudi Arabia (22.55%), China and India (20.47%), Americas (10.24%), and other nations (2.61%). Most of the manufactured drugs were prescription drugs (90.62%). In this work, the local pharmaceutical industry with the highest percentage of contribution to local drug security was Pharmaceutical Solution Industries (PSI), representing the 5% of the items available in the Saudi mar-ket. The second highest percentage was 4% by TABUK Pharmaceutical Manufacturing CO., followed by SPIMACO (3%), JAMJOOM pharmaceutical company (2%), Riyadh pharma (2%), and Jazeera pharmaceuti-cal industries (2%). In addition, results from this study provide information about the most essential phar-maceutical products that needs to be nationally manufactured or increased in production in order to rise the contribution of local pharmaceutical industries in Saudi drug security. Unfortunately, the small con-tribution of the Saudi pharmaceutical industry in local drug security increases the burden on the Kingdom's annual budget due to the over-reliance on international pharmaceuticals.(c) 2023 The Authors. Published by Elsevier B.V. on behalf of King Saud University. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).

Automated summary

This study explores the contribution of the local pharmaceutical industry to drug security in Saudi Arabia. The majority of drugs in the market are manufactured in Europe, followed by Saudi Arabia, China, and India. Most of the manufactured drugs are prescription drugs. The highest contributors to local drug security are Pharmaceutical Solution Industries (PSI), followed by TABUK Pharmaceutical Manufacturing CO., SPIMACO, JAMJOOM pharmaceutical company, Riyadh pharma, and Jazeera pharmaceutical industries.